About SEngine Precision Medicine
SEngine Precision Medicine is a company based in Seattle (United States) founded in 2015.. SEngine Precision Medicine has raised $27.35 million across 5 funding rounds from investors including Washington Research Foundation and Alethea. SEngine Precision Medicine offers products and services including PARIS Test and Drug Development Platform. SEngine Precision Medicine operates in a competitive market with competitors including GRAIL, Color, Earli, RainDance and NovellusDx, among others.
- Headquarter Seattle, United States
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$27.35 M (USD)
in 5 rounds
-
Latest Funding Round
$600 K (USD), Series A
Mar 10, 2023
-
Investors
Washington Research Foundation
& 1 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of SEngine Precision Medicine
SEngine Precision Medicine offers a comprehensive portfolio of products and services, including PARIS Test and Drug Development Platform. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Tests cancer drugs on tumor organoids for personalized treatment options.
Leverages test data to accelerate new cancer drug creation processes.
Unlock access to complete
Unlock access to complete
Funding Insights of SEngine Precision Medicine
SEngine Precision Medicine has successfully raised a total of $27.35M across 5 strategic funding rounds. The most recent funding activity was a Series A round of $600 thousand completed in March 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 5
- Last Round Series A — $600,000
-
First Round
First Round
(29 Oct 2018)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar, 2023 | Amount | Series A - SEngine Precision Medicine | Valuation |
investors |
|
| Jul, 2022 | Amount | Series A - SEngine Precision Medicine | Valuation | Washington Research Foundation | |
| Oct, 2019 | Amount | Series A - SEngine Precision Medicine | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in SEngine Precision Medicine
SEngine Precision Medicine has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include Washington Research Foundation and Alethea. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage venture capital is provided to US companies across sectors.
|
Founded Year | Domain | Location | |
|
Alethea Capital Management, LLC is engaged in investment advisory services.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by SEngine Precision Medicine
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - SEngine Precision Medicine
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Sengine Precision Medicine Comparisons
Competitors of SEngine Precision Medicine
SEngine Precision Medicine operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GRAIL, Color, Earli, RainDance and NovellusDx, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Circulating tumor DNA is screened for early cancer detection.
|
|
| domain | founded_year | HQ Location |
Cancer care is delivered through a virtual clinic by Color.
|
|
| domain | founded_year | HQ Location |
Early cancer detection tests are developed using synthetic biomarkers.
|
|
| domain | founded_year | HQ Location |
Developer of nucleic acid detection and quantification systems
|
|
| domain | founded_year | HQ Location |
Developer of technology for precision cancer diagnosis and therapies
|
|
| domain | founded_year | HQ Location |
Tumor response to cancer therapies is monitored via specialized assays.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Sengine Precision Medicine
Frequently Asked Questions about SEngine Precision Medicine
When was SEngine Precision Medicine founded?
SEngine Precision Medicine was founded in 2015 and raised its 1st funding round 3 years after it was founded.
Where is SEngine Precision Medicine located?
SEngine Precision Medicine is headquartered in Seattle, United States. It is registered at Seattle, Washington, United States.
Is SEngine Precision Medicine a funded company?
SEngine Precision Medicine is a funded company, having raised a total of $27.35M across 5 funding rounds to date. The company's 1st funding round was a Series A of $8.65M, raised on Oct 29, 2018.
What does SEngine Precision Medicine do?
SEngine Precision Medicine was founded in 2015 in Seattle, United States, within the biotechnology sector. A platform for precision medicine is provided, relying on patient-derived organoids to identify novel drug targets. Synthetic lethality concepts are integrated to address undruggable oncogenes and tumor suppressor losses. Targeted drug candidates are screened on human disease samples through in vitro clinical trials, supporting pipeline acceleration.
Who are the top competitors of SEngine Precision Medicine?
What products or services does SEngine Precision Medicine offer?
SEngine Precision Medicine offers PARIS Test and Drug Development Platform.
Who are SEngine Precision Medicine's investors?
SEngine Precision Medicine has 2 investors. Key investors include Washington Research Foundation, and Alethea.